PACTIMMUNE Trademark

Trademark Overview


On Wednesday, July 7, 2021, a trademark application was filed for PACTIMMUNE with the United States Patent and Trademark Office. The USPTO has given the PACTIMMUNE trademark a serial number of 90815371. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 20, 2023. This trademark is owned by PACT Pharma, Inc.. The PACTIMMUNE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Immune cell-based genetic analysis services for scientific research and development purposes; immune cell-based genetic screening for scientific research and development purposes; immune cell-based genetic testing for scientific research purposes; medical and scientific immune cell-based research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing medical and scientific immune cell-based research information in the field of clinical trials; providing medical and scientific immune cell-based research information in the fields of pharmaceuticals and immune cell genetics; scientific research in the field of immune cell-based genetics and genetic engineering; Providing medical testing services in the field of cancer research and disease classification at the molecular level; Laboratory services provided to generate immune cell receptor data for research and the development of diagnostic tests; providing medical diagno...
pactimmune

General Information


Serial Number90815371
Word MarkPACTIMMUNE
Filing DateWednesday, July 7, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 20, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 21, 2021

Trademark Statements


Pseudo MarkPACT IMMUNE
Goods and ServicesImmune cell-based genetic analysis services for scientific research and development purposes; immune cell-based genetic screening for scientific research and development purposes; immune cell-based genetic testing for scientific research purposes; medical and scientific immune cell-based research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing medical and scientific immune cell-based research information in the field of clinical trials; providing medical and scientific immune cell-based research information in the fields of pharmaceuticals and immune cell genetics; scientific research in the field of immune cell-based genetics and genetic engineering; Providing medical testing services in the field of cancer research and disease classification at the molecular level; Laboratory services provided to generate immune cell receptor data for research and the development of diagnostic tests; providing medical diagnostic and prognostic testing services; scientific research and development services; providing an online computer database in the field of immune cell genetics

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, September 15, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePACT Pharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NamePACT Pharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Monday, March 20, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 20, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, August 13, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 11, 2022SOU EXTENSION 1 GRANTED
Thursday, August 11, 2022SOU EXTENSION 1 FILED
Thursday, August 11, 2022TEAS EXTENSION RECEIVED
Tuesday, February 15, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 21, 2021PUBLISHED FOR OPPOSITION
Wednesday, December 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, November 12, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, November 12, 2021EXAMINER'S AMENDMENT ENTERED
Friday, November 12, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, November 12, 2021EXAMINERS AMENDMENT E-MAILED
Friday, November 12, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, October 5, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 5, 2021NON-FINAL ACTION E-MAILED
Tuesday, October 5, 2021NON-FINAL ACTION WRITTEN
Monday, September 27, 2021ASSIGNED TO EXAMINER
Wednesday, September 15, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 10, 2021NEW APPLICATION ENTERED